[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337993-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337993-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","reciprocal-interactions-between-lncrnas-and-myc-in-colorectal-cancer-partners-in-crime-review-article-open","Reciprocal interactions between lncRNAs and MYC in colorectal cancer - partners in crime - Review Article Open","","Advanced colorectal cancer features high mortality and rising early-onset incidence, with genetic and epigenetic heterogeneity contributing to disease progression. Proto-oncogenic MYC is frequently dysregulated and drives transcriptional control of many cancer-relevant metabolic programs and downstream targets. Long noncoding RNAs (lncRNAs) regulate gene expression at multiple levels and can both control MYC and be controlled by MYC in a reciprocal axis. This review synthesizes current knowledge of the MYC–lncRNA regulatory network in colorectal cancer and highlights potential therapeutic opportunities targeting MYC or lncRNAs and their interactions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/reciprocal-interactions-between-lncrnas-and-myc-in-colorectal-cancer-partners-in-crime-review-article-open/337993/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/reciprocal-interactions-between-lncrnas-and-myc-in-colorectal-cancer-partners-in-crime-review-article-open/337993.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is MYC considered a key driver in colorectal cancer?","Question",{"text":63,"@type":64},"MYC is frequently dysregulated in colorectal cancer and regulates transcription of many genes that support tumor-relevant molecular functions, including major metabolic pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do lncRNAs interact with MYC in colorectal cancer?",{"text":68,"@type":64},"LncRNAs can control MYC expression at transcriptional and post-transcriptional levels, while MYC can also promote or inhibit lncRNA transcription and influence cell fate through reciprocal regulation.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic directions are discussed for targeting the MYC–lncRNA axis?",{"text":72,"@type":64},"The review notes that MYC and lncRNAs have been elusive clinical targets, but new inhibitors and administration strategies offer hope for therapies targeting MYC, lncRNAs, or their interaction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337993,1790807645,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nREVIEW ARTICLE OPEN   \nReciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime  \nZhen Lei 1,3, Zhipu Zhu1,3, Zhihui Yao1,3, Xiangyu Dai1, Yi Dong 1, Bing Chen 1, Songyu Wang 1, Siyue Wang 1, Lutterodt Bentum-Ennin2, Lei Jin 1 ✉, Hao Gu 2 ✉ and Wanglai Hu 1,2 ✉  \n© The Author(s) 2024  \n\n| | Proto-oncogenic MYC is frequently dysregulated in colorectal cancer (CRC) . In the past decades, long noncoding RNAs (lncRNAs) have emerged as important regulators in cancers, acting as scaffolds, molecular decoys, post-transcriptional regulators, and others. Interestingly, lncRNAs are able to control MYC expression both at transcriptional and post-transcriptional levels. It is suggested that the reciprocal interaction of MYC and lncRNAs often occurs in CRC. MYC can affect the cell fate by promoting or inhibiting the transcription of some lncRNAs. At the same time, some lncRNAs can also affect MYC expression or transcriptional activity, and in turn decide the cell fate. In this review we summarized the current knowledge about the MYC and lncRNA axis, focusing on its | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | mutual regulation, roles in CRC, and proposed potential therapeutic prospects for CRC treatment. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2024)15:539; [https://doi.org/10.1038/s41419-024-06918-w](https://doi.org/10.1038/s41419-024-06918-w) |  |\n|  |  |  |\n\nFACTS  \n● MYC is responsible for regulating a plethora of genes directing a range of molecular functions.  \n● A deregulated expression and/or activity of MYC is a common observation in CRC.  \n● LncRNAs are emerging as important factors in cancers by regulating gene expression on multiple levels.  \n● Both MYC and lncRNAs have been elusive targets clinically. Recently, however, the discovery of novel inhibitors, as well as, new forms of administration have brought new hope to the search for therapies targeting MYC and lncRNAs.  \nOPEN QUESTIONS  \n● How do we limit the pro-oncogenic function of lncRNAs and MYC more effectively? Should we target lncRNAs or disrupt the interaction between lncRNAs and MYC?  \n● Will the interaction between MYC and lncRNAs differ in other tumors besides colorectal cancer?  \n● Is there a similar relationship between lncRNAs and MYC in immune cells? Can targeting MYC or lncRNAs advance the course of cancer immunotherapy?  \nINTRODUCTION  \nAdvanced colorectal cancer (CRC) is a pervasive cancer with a high mortality rate. Worldwide in 2022, 1.9 million people were  \ndiagnosed with CRC with 904,000 lives being lost to this disease [1] . Unfortunately, the tide of early-onset CRC is rising, and these younger individuals are presenting with predominantly distal tumors, a site of occurrence known to present with a worsened prognosis [2, 3] . Obesity, heredity, and diet contribute to the CRC development [4] with smoking also considered as a major risk factor for CRC [5] . As with most sporadic cancers, individual cases of CRC are highly heterogenous, with several studies identifying the dysregulation of multiple genes arising from a range of genetic and epigenetic causes that affect both coding and noncoding genes [6–10] .  \nOne of the most common changes occurring in CRC and over 70% of other cancers involves the abnormal expression and/or activity of MYC [11], attracting a great deal of research attention. MYC is a transcription factor belonging to the MYC family [12] and is responsible for regulating the transcription of a plethora of genes directing a range of molecular functions. Notably, MYCis not only essential for maintaining normal cellular homeostasis where its expression is strictly regulated but its dysregulation appears to be equally important for tumor development and progression. Indeed, evidence continues to build up linking MYC with the control of hallmark metabolic pathways in cancer cells including glycolysis","cbCaim4XCj9EAh7T","https://ap.wps.com/l/cbCaim4XCj9EAh7T","pdf",1207642,"English","# Introduction\n# FACTS\n# OPEN QUESTIONS\n# MYC and lncRNAs in colorectal cancer","[{\"question\":\"Why is MYC considered a key driver in colorectal cancer?\",\"answer\":\"MYC is frequently dysregulated in colorectal cancer and regulates transcription of many genes that support tumor-relevant molecular functions, including major metabolic pathways.\"},{\"question\":\"How do lncRNAs interact with MYC in colorectal cancer?\",\"answer\":\"LncRNAs can control MYC expression at transcriptional and post-transcriptional levels, while MYC can also promote or inhibit lncRNA transcription and influence cell fate through reciprocal regulation.\"},{\"question\":\"What therapeutic directions are discussed for targeting the MYC–lncRNA axis?\",\"answer\":\"The review notes that MYC and lncRNAs have been elusive clinical targets, but new inhibitors and administration strategies offer hope for therapies targeting MYC, lncRNAs, or their interaction.\"}]","Reciprocal interactions between lncRNAs and MYC in colorectal cancer - partners in crime - Review Article Open | PDF",1790021471,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ec1e19ea2552cf3713d666c72d7b5b3.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b652dac2148e8b331425a95c986c2a4d.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54327406dc953be08150d38efcede000.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b23bf467643e7a246c48d6c0ae0f19d3.webp",980,1301]